Flavia Varano
5PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 08, 2022
CK1 delta inhibition: an emerging strategy to combat neurodegenerative diseases.Flavia Varano, Daniela Catarzi, Sara Calenda
|Aug 28, 2019
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-<i>a</i>]pyrazin-3-one Derivatives: Highly Potent and Selective Human A<sub>2A</sub> Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain.Matteo Falsini, Daniela Catarzi, Flavia Varano
|Jul 16, 2019
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity.Marco Betti, Daniela Catarzi, Flavia Varano
|Jun 29, 2017
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold To Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII.Matteo Falsini, Lucia Squarcialupi, Daniela Catarzi
|Jun 08, 2017
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A<sub>2A</sub> Receptor Subtype.Matteo Falsini, Lucia Squarcialupi, Daniela Catarzi
Pageof 1
